SK284901B6 - Pevný orálny farmaceutický prostriedok s kontrolovane uvoľňujúcou matricou obsahujúcou tilidínmezylát - Google Patents

Pevný orálny farmaceutický prostriedok s kontrolovane uvoľňujúcou matricou obsahujúcou tilidínmezylát Download PDF

Info

Publication number
SK284901B6
SK284901B6 SK892-2001A SK8922001A SK284901B6 SK 284901 B6 SK284901 B6 SK 284901B6 SK 8922001 A SK8922001 A SK 8922001A SK 284901 B6 SK284901 B6 SK 284901B6
Authority
SK
Slovakia
Prior art keywords
tilidine
pharmaceutical composition
mesylate
solid oral
oral pharmaceutical
Prior art date
Application number
SK892-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK8922001A3 (en
Inventor
Richard Hirsch
Martin Wesseling
Thomas Str�Ngmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of SK8922001A3 publication Critical patent/SK8922001A3/sk
Publication of SK284901B6 publication Critical patent/SK284901B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK892-2001A 1998-12-23 1999-12-23 Pevný orálny farmaceutický prostriedok s kontrolovane uvoľňujúcou matricou obsahujúcou tilidínmezylát SK284901B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19859636A DE19859636A1 (de) 1998-12-23 1998-12-23 Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
PCT/EP1999/010381 WO2000038656A1 (de) 1998-12-23 1999-12-23 Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff

Publications (2)

Publication Number Publication Date
SK8922001A3 SK8922001A3 (en) 2001-12-03
SK284901B6 true SK284901B6 (sk) 2006-02-02

Family

ID=7892368

Family Applications (1)

Application Number Title Priority Date Filing Date
SK892-2001A SK284901B6 (sk) 1998-12-23 1999-12-23 Pevný orálny farmaceutický prostriedok s kontrolovane uvoľňujúcou matricou obsahujúcou tilidínmezylát

Country Status (21)

Country Link
US (1) US6579536B1 (cs)
EP (1) EP1140031B1 (cs)
JP (1) JP2002533381A (cs)
AT (1) ATE252377T1 (cs)
AU (1) AU770293B2 (cs)
BR (1) BR9916575A (cs)
CA (1) CA2355891A1 (cs)
CZ (1) CZ301628B6 (cs)
DE (2) DE19859636A1 (cs)
DK (1) DK1140031T3 (cs)
ES (1) ES2207334T3 (cs)
HU (1) HUP0104647A3 (cs)
MX (1) MXPA01006493A (cs)
NO (1) NO320022B1 (cs)
NZ (1) NZ512079A (cs)
PL (1) PL199024B1 (cs)
PT (1) PT1140031E (cs)
SK (1) SK284901B6 (cs)
TR (1) TR200101864T2 (cs)
WO (1) WO2000038656A1 (cs)
ZA (1) ZA200105040B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1685839T3 (da) 1997-12-22 2013-06-24 Euro Celtique Sa Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
AU776666B2 (en) 2000-02-08 2004-09-16 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
PL357158A1 (en) * 2000-02-08 2004-07-12 Euro-Celtique, S.A. Controlled-release compositions containing opioid agonist and antagonist
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
CA2478515C (en) * 2002-04-05 2010-09-28 Purdue Pharma Pharmaceutical preparation containing oxycodone and naloxone
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
DE10233108A1 (de) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
JP2008507508A (ja) * 2004-07-22 2008-03-13 株式會社アモーレパシフィック トピラメート徐放性製剤及びその製造方法
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
EP2168945A1 (en) * 2008-09-26 2010-03-31 Hexal Ag Crystalline forms of Tilidine Mesylate
DK3045043T3 (da) 2009-02-26 2020-08-03 Relmada Therapeutics Inc Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
WO2010103039A1 (en) 2009-03-10 2010-09-16 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
KR20180037074A (ko) 2013-07-23 2018-04-10 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
RU2017106028A (ru) 2014-09-19 2018-10-22 Дзе Проктер Энд Гэмбл Компани Лекарственная форма фенилэфрина с пульсирующим высвобождением
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71847A1 (cs) * 1975-02-14 1977-01-05
EP0665830B1 (de) * 1992-10-26 1997-03-12 Gödecke Aktiengesellschaft Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19710008A1 (de) 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
ATE242760T1 (de) 1998-04-28 2003-06-15 Russinsky Ltd Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
DE59907481D1 (de) 2003-11-27
CZ301628B6 (cs) 2010-05-05
DK1140031T3 (da) 2003-12-01
NO320022B1 (no) 2005-10-10
EP1140031B1 (de) 2003-10-22
ATE252377T1 (de) 2003-11-15
DE19859636A1 (de) 2000-06-29
US6579536B1 (en) 2003-06-17
NO20013060L (no) 2001-06-20
ES2207334T3 (es) 2004-05-16
AU2286200A (en) 2000-07-31
AU770293B2 (en) 2004-02-19
TR200101864T2 (tr) 2002-01-21
ZA200105040B (en) 2002-05-22
NO20013060D0 (no) 2001-06-20
CA2355891A1 (en) 2000-07-06
HK1039273A1 (en) 2002-04-19
JP2002533381A (ja) 2002-10-08
WO2000038656A1 (de) 2000-07-06
MXPA01006493A (es) 2002-06-04
PL348419A1 (en) 2002-05-20
BR9916575A (pt) 2001-09-18
HUP0104647A2 (hu) 2002-03-28
CZ20012167A3 (cs) 2001-11-14
SK8922001A3 (en) 2001-12-03
PT1140031E (pt) 2004-03-31
EP1140031A1 (de) 2001-10-10
PL199024B1 (pl) 2008-08-29
NZ512079A (en) 2003-08-29
HUP0104647A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
US9675611B1 (en) Methods of providing analgesia
SK8922001A3 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
US9669023B2 (en) Controlled release hydrocodone formulations
PL196263B1 (pl) Farmaceutyczna postać dawkowania o przedłużonym uwalnianiu ranolazyny do stosowania ustnego
CA2199345A1 (en) Controlled-release composition
US10179130B2 (en) Controlled release hydrocodone formulations
JP2000212069A (ja) 有効物質の放出が調節された鎮痛薬
JP2023505329A (ja) リオシグアトの放出調節医薬組成物
WO2006103551A1 (en) Controlled release formulations of oxycodone
DE19920415A1 (de) Metamizol enthaltende, kontrolliert freisetzende pharmazeutische Zusammensetzung
HK1039273B (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
WO2015150948A1 (en) Modified release solid oral pharmaceutical compositions of cyclobenzaprine or a salt thereof
MXPA01007814A (es) Formulacion farmaceutica de libekracion prolongada independiente al ph